Fludarabine plus high dose melphalan or busulphan are reduced intensity but truly myeloablative conditioning regimens

被引：0
|
作者：
Pardo Gonzalez, C. [1 ]
Gonzalez, A. [1 ]
Fernandez, R. [1 ]
Gonzalez, A. [1 ]
Palomo, P. [1 ]
Gonzalez, S. [1 ]
Arija, E. [1 ]
Martinez-Mugica, C. [1 ]
Rayon, C. [1 ]
Vallejo, C. [1 ]
机构：
[1] Hosp Univ Cent Asturias, Oviedo, Spain
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S237 / S238
页数：2
相关论文
共 50 条
  • [41] Fludarabine Busulfan Compared to Fludarabine Melphalan Is Associated with Increased Relapse Risk in Reduced Intensity Conditioning Transplant Despite Pharmacokinetic Dosing
    Damlaj, Moussab
    Alkhateeb, Hassan B.
    Partain, Daniel K.
    Almasri, Jehad
    Hefazi, Mehrdad
    Hashmi, Shahrukh K.
    Gastineau, Dennis A.
    Al-Kali, Aref
    Wolf, Robert C.
    Gangat, Naseema
    Litzow, Mark R.
    Hogan, William J.
    Patnaik, Mrinal M.
    BLOOD, 2015, 126 (23)
  • [42] Comparison of myeloablative and reduced intensity conditioning regimens in haploidentical peripheral blood stem cell transplantation
    Modi, Dipenkumar
    Kim, Seongho
    Deol, Abhinav
    Ayash, Lois
    Ratanatharathorn, Voravit
    Uberti, Joseph P.
    BONE MARROW TRANSPLANTATION, 2021, 56 (03) : 741 - 744
  • [43] Allogeneic HSCT with reduced intensity versus myeloablative conditioning regimens in paediatric acute lymphoblastic leukaemia
    Semenova, E.
    Stancheva, N.
    Kazantsev, I.
    Vasilieva, Y.
    Kostorov, V.
    Shiryaev, S.
    Afanasyev, B.
    Zubarovskaya, L.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S285 - S285
  • [44] More frequently employed conditioning regimens in allo-HSCT: conventional or reduced intensity but myeloablative
    Rodriguez, M.
    Barragan, L.
    Lizardi, A.
    Ferreiro, J.
    Alkorta, A.
    Artola, T.
    Perez, E.
    Caminos, N.
    Sirvent, M.
    Araiz, M.
    Vallejo, C.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S332 - S332
  • [45] MYELOABLATIVE CONDITIONING WITH INTRAVENOUS BUSULPHAN IN A SINGLE DAILY DOSE AND FLUDARABINE (BUF) FOR HLA-IDENTICAL SIBLING ALLOGENEIC HSCT IN MYELOID MALIGNANCIES
    De la Serna, J.
    Bermudez, A.
    Sanz, J.
    Caballero, D.
    De la Camara, R.
    Vallejo, C.
    Serrano, D.
    Moraleda, J. M.
    Benlloch, L.
    Sanz, G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S299 - S299
  • [46] Fludarabine and Melphalan Results in Fewer Relapses Compared to Fludarabine and Targeted Busulfan in Patients Receiving Reduced Intensity Conditioning for AML and MDS
    Caddell, Ryan James
    Schaible, Braydon
    Ma, Zhenjun
    Dimaggio, Elizabeth
    Tombleson, Rebecca
    Anasetti, Claudio
    Ayala, Ernesto
    Betts, Brian C.
    Kharfan-Dabaja, Mohamed A.
    Locke, Frederick L.
    Nishihori, Taiga
    Pidala, Joseph A.
    Fernandez, Hugo F.
    Mishra, Asmita
    BLOOD, 2016, 128 (22)
  • [47] A Single-Center Experience Comparing Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning with Myeloablative Busulfan, Cyclophosphamide, and Antithymocyte Globulin for Chronic Granulomatous Disease
    Khandelwal, Pooja
    Bleesing, Jacob J.
    Davies, Stella M.
    Marsh, Rebecca A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (11) : 2011 - 2018
  • [48] Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT
    Ciurea, S. O.
    Saliba, R.
    Rondon, G.
    Pesoa, S.
    Cano, P.
    Fernandez-Vina, M.
    Qureshi, S.
    Worth, L. L.
    McMannis, J.
    Kebriaei, P.
    Jones, R. B.
    Korbling, M.
    Qazilbash, M.
    Shpall, E. J.
    Giralt, S.
    de Lima, M.
    Champlin, R. E.
    Gajewski, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 (03) : 429 - 436
  • [49] Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
    Akanksha Chichra
    Lingaraj Nayak
    Rushabh Kothari
    Siddhesh Kalantri
    Avinash Bonda
    Anant Gokarn
    Sachin Punatar
    Sumeet Mirgh
    Nishant Jindal
    Bhausaheb Bagal
    Sadhana Kannan
    Libin Mathew
    Navin Khattry
    International Journal of Hematology, 2024, 119 : 71 - 79
  • [50] Treosulphan as alternative to busulphan for myeloablative and reduced-intensity conditioning regimen of allogeneic bone marrow transplantation for high-risk paediatric patients
    Zaidman, I.
    Gefen, R.
    Kasis, I.
    Mandel, H.
    Porat, I.
    Ofir, R.
    Hadad, S.
    Ben Arush, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S365 - S365
12345